Jane Street Group, LLC Gbs Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.0 - $0.47 $0 - $5,264	11,202 New	11,202 $0
Q1 2022 May 17, 2022	SELL	$0.43 - $1.7 $10,829 - $42,812	-25,184 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$1.26 - $2.45 $31,731 - $61,700	25,184 New	25,184 $36,000
Q3 2021 Nov 16, 2021	SELL	$2.26 - $4.29 $43,231 - $82,063	-19,129 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.65 - $5.72 $50,691 - $109,417	19,129 New	19,129 $75,000
Q1 2021 May 18, 2021	SELL	$5.21 - $8.25 $84,308 - $133,501	-16,182 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$7.4 - $11.02 $119,746 - $178,325	16,182 New	16,182 $120,000

Ticker GBS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,889,900
Description
GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, t...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.